Literature DB >> 23469216

Distinct signal transduction pathways downstream of the (P)RR revealed by microarray and ChIP-chip analyses.

Daniela Zaade1, Jennifer Schmitz, Eileen Benke, Sabrina Klare, Kerstin Seidel, Sebastian Kirsch, Petra Goldin-Lang, Frank S Zollmann, Thomas Unger, Heiko Funke-Kaiser.   

Abstract

The (pro)renin receptor ((P)RR) signaling is involved in different pathophysiologies ranging from cardiorenal end-organ damage via diabetic retinopathy to tumorigenesis. We have previously shown that the transcription factor promyelocytic leukemia zinc finger (PLZF) is an adaptor protein of the (P)RR. Furthermore, recent publications suggest that major functions of the (P)RR are mediated ligand-independently by its transmembrane and intracellular part, which acts as an accessory protein of V-ATPases. The transcriptome and recruitmentome downstream of the V-ATPase function and PLZF in the context of the (P)RR are currently unknown. Therefore, we performed a set of microarray and chromatin-immunoprecipitation (ChIP)-chip experiments using siRNA against the (P)RR, stable overexpression of PLZF, the PLZF translocation inhibitor genistein and the specific V-ATPase inhibitor bafilomycin to dissect transcriptional pathways downstream of the (P)RR. We were able to identify distinct and overlapping genetic signatures as well as novel real-time PCR-validated target genes of the different molecular functions of the (P)RR. Moreover, bioinformatic analyses of our data confirm the role of (P)RŔs signal transduction pathways in cardiovascular disease and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23469216      PMCID: PMC3587649          DOI: 10.1371/journal.pone.0057674

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  69 in total

Review 1.  Renin, prorenin and the putative (pro)renin receptor.

Authors:  A H Jan Danser; Jaap Deinum
Journal:  Hypertension       Date:  2005-09-26       Impact factor: 10.190

Review 2.  Prorenin and the (pro)renin receptor--an update.

Authors:  A H Jan Danser; Wendy W Batenburg; Joep H M van Esch
Journal:  Nephrol Dial Transplant       Date:  2007-01-27       Impact factor: 5.992

3.  Identification of apoptosis-related PLZF target genes.

Authors:  Maria Victoria Bernardo; Estefanía Yelo; Lourdes Gimeno; José Antonio Campillo; Antonio Parrado
Journal:  Biochem Biophys Res Commun       Date:  2007-05-24       Impact factor: 3.575

4.  Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes.

Authors:  David G DeNardo; Hee-Tae Kim; Susan Hilsenbeck; Valerie Cuba; Anna Tsimelzon; Powel H Brown
Journal:  Mol Endocrinol       Date:  2004-10-28

5.  The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1.

Authors:  Ryuji Ikeda; Kenichi Yoshida; So Tsukahara; Yoshiko Sakamoto; Hiroshi Tanaka; Ken-ichi Furukawa; Ituro Inoue
Journal:  J Biol Chem       Date:  2004-12-28       Impact factor: 5.157

6.  A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor.

Authors:  Juliane Ramser; Fatima E Abidi; Celine A Burckle; Claus Lenski; Helga Toriello; Gaiping Wen; Herbert A Lubs; Stefanie Engert; Roger E Stevenson; Alfons Meindl; Charles E Schwartz; Genevieve Nguyen
Journal:  Hum Mol Genet       Date:  2005-03-03       Impact factor: 6.150

7.  Aliskiren.

Authors:  Morris J Brown
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

8.  Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren.

Authors:  Jan H Schefe; Christian Neumann; Matthias Goebel; Jan Danser; Sebastian Kirsch; Ronald Gust; Ulrich Kintscher; Thomas Unger; Heiko Funke-Kaiser
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

9.  Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.

Authors:  Y Huang; S Wongamorntham; J Kasting; D McQuillan; R T Owens; L Yu; N A Noble; W Border
Journal:  Kidney Int       Date:  2006-01       Impact factor: 18.998

10.  MeCP2, a key contributor to neurological disease, activates and represses transcription.

Authors:  Maria Chahrour; Sung Yun Jung; Chad Shaw; Xiaobo Zhou; Stephen T C Wong; Jun Qin; Huda Y Zoghbi
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

View more
  2 in total

Review 1.  The (pro)renin receptor in health and disease.

Authors:  Atsuhiro Ichihara; Midori Sasaki Yatabe
Journal:  Nat Rev Nephrol       Date:  2019-11       Impact factor: 28.314

2.  Regulation of growth hormone secretion by (pro)renin receptor.

Authors:  Yuji Tani; Shozo Yamada; Naoko Inoshita; Yukio Hirata; Masayoshi Shichiri
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.